Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes
Jessamy C Tiffen, Dilini Gunatilake, Stuart J Gallagher, Kavitha Gowrishankar, Anja Heinemann, Carleen Cullinane, Ken Dutton-Regester, Gulietta M Pupo, Dario Strbenac, Jean Y Yang, Jason Madore, Graham J Mann, Nicholas K Hayward, Grant A McArthur, Fabian V Filipp, Peter Hersey
Oncotarget | IMPACT JOURNALS LLC | Published : 2015
Awarded by NHMRC program
Awarded by NCI
Awarded by Deutsche Forschungsgemeinschaft (DFG)
Awarded by NATIONAL CANCER INSTITUTE
This work is supported by NHMRC program grant 633004; the Melanoma Institute of Australia; Cancer Institute NSW. The MD Anderson RPPA Core Facility is supported by NCI grant no. CA16672. AH is supported by Deutsche Forschungsgemeinschaft (DFG project no: HE 6983/1-1).